Clinical epidemiology of heart failure: public and private health burden

McMurray, J.J. , Petrie, M.C. , Murdoch, D.R. and Davie, A.P. (1998) Clinical epidemiology of heart failure: public and private health burden. European Heart Journal, 19 Sup, P9-16. (PMID:9886707)

Full text not currently available from Enlighten.


Clinically overt heart failure is common, costly, disabling, and deadly; it remains so despite the tremendous benefit of angiotensin-converting enzyme inhibitors. Better treatments for and earlier detection of heart failure are needed if the situation to improve. However, even this may not be enough. The dramatic deterioration in quality of life and prognosis when a patient progresses from asymptomatic left ventricular dysfunction to overt heart failure suggests that only a programme of screening and prevention will effectively reduce the public health burden of heart failure. Moreover, the economic consequences of developing overt heart failure suggest that such an approach is likely to be cost-effective.

Item Type:Articles
Glasgow Author(s) Enlighten ID:Petrie, Professor Mark and Murdoch, Dr David and McMurray, Professor John
Authors: McMurray, J.J., Petrie, M.C., Murdoch, D.R., and Davie, A.P.
College/School:College of Medical Veterinary and Life Sciences > Institute of Cardiovascular and Medical Sciences
College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing
Journal Name:European Heart Journal
Publisher:Oxford University Press
ISSN (Online):1522-9645

University Staff: Request a correction | Enlighten Editors: Update this record